Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 80377 refers to a laboratory test that is conducted to definitively, qualitatively, or quantitatively measure seven or more drug(s) or substance(s) that are not otherwise specified. This code is utilized in scenarios where a comprehensive analysis of multiple substances is required, allowing healthcare professionals to obtain critical information regarding a patient's exposure to various drugs. The testing methodologies commonly employed for this purpose include gas chromatography, liquid chromatography, and tandem mass spectrometry, either individually or in combination. These advanced techniques enable precise identification and quantification of substances, which is essential for effective patient management and treatment decisions. It is important to note that this code is part of a broader coding system where code 80375 is designated for testing 1-3 drugs or substances, and code 80376 is applicable for 4-6 drugs or compounds. Therefore, CPT® Code 80377 specifically addresses the need for extensive drug screening when multiple substances are suspected or need to be monitored in a patient's sample.
© Copyright 2026 Coding Ahead. All rights reserved.
The CPT® Code 80377 is indicated for use in situations where there is a need to perform a comprehensive analysis of drug(s) or substance(s) in a patient sample. This may include, but is not limited to, the following conditions:
The procedure associated with CPT® Code 80377 involves several key steps to ensure accurate and reliable results. The following outlines the procedural steps:
Post-procedure care following the testing associated with CPT® Code 80377 typically involves the interpretation of results by the healthcare provider. The provider will review the findings in conjunction with the patient's clinical history and any relevant symptoms. Depending on the results, further action may be required, such as adjustments to medication, referrals to specialists, or additional testing. It is also important for the provider to discuss the results with the patient, addressing any concerns and outlining the next steps in their care plan. Additionally, documentation of the results and any follow-up actions taken is essential for maintaining accurate medical records and ensuring continuity of care.
| Short Descr | DRUG/SUBSTANCE NOS 7/MORE | Medium Descr | DRUG/SUBSTANCE DEFINITIVE QUAL/QUANT NOS 7/MORE | Long Descr | Drug(s) or substance(s), definitive, qualitative or quantitative, not otherwise specified; 7 or more | Status Code | Not Valid for Medicare Purposes | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Code Not Recognized by OPPS when submitted on Outpatient Hospital Part B Bill Type (12x/13x) | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T2D - Other tests - other | MUE | 1 |
| 90 | Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number. |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2015-01-01 | Added | Added |
Get instant expert-level medical coding assistance.